Skip to content 
AMM 54: Restylane Shaype: Transforming Chin Augmentation for Aesthetic Excellence
April 22, 2024
Dive into the latest advancements in acne treatment on today’s episode of the Aesthetic Medicine Minute. Join us as we delve into Allergan Aesthetics’ new product launch that could change the game for those with acne-prone skin. First on the list is a spot treatment formulated to quickly diminish blemishes, offering swift relief for unexpected acne flare-ups. Adding to their innovative repertoire is a balancing moisturizer crafted to hydrate while regulating oil production, a crucial concern for those balancing moisture and oil control. Discover how these products blend high-quality, medical-grade ingredients with natural botanicals, embodying Allergan Aesthetics’ mission to harmonize scientific innovation with Mother Nature in skincare. Tune in to explore these groundbreaking solutions and find renewed hope in the fight against acne with the Aesthetic Medicine Minute.
Quick Takes
- The study evaluates a new hyaluronic acid filler, Restylane Shaype, for improving non-surgical chin augmentation.
- Shaype was found to be effective and safe, with high patient satisfaction and a notable improvement in chin retrusion in participants.
- This evidence supports Restylane Shaype as a promising non-surgical option to enhance chin profile, using NASHA-HD technology for a natural contour.
Episode Transcript
Welcome to the Aesthetic Medicine Minute. Today, April 22nd, we’re discussing an article published in the April 2024 issue of the Journal of Drugs in Dermatology that explores a new hyaluronic acid (HA) filler, Restylane Shaype. The study, led by Dr. Andreas Nikolis and a team of respected clinicians, reports on a filler designed to improve the non-surgical approach to chin augmentation.
The product, known as Shaype, was evaluated for its effectiveness and safety in correcting chin retrusion—a condition where the chin projects less than desired. This hyaluronic acid boasts high G prime, indicating strength and firmness, making it suitable for placement on the bone to mimic the chin’s natural contour.
The study randomly assigned participants to either Shaype injections or no treatment, and measured outcomes through the Global Aesthetic Improvement Scale and the Galderma Chin Retrusion Scale, alongside patient satisfaction surveys.
Results revealed an 83.3% improvement in patients receiving Shaype, and high satisfaction rates persisted throughout the 12-month follow-up period. Additionally, reported adverse events were mostly mild and transient, with no serious issues.
This evidence suggests that Restylane Shaype, employing NASHA-HD technology, is a safe and effective non-surgical alternative for enhancing chin profile and overall facial aesthetics. For practitioners and patients alike, it seems we have another promising tool to sculpt confidence while minimizing risks. Stay tuned as we continue to follow advancements in aesthetic medicine that blend cutting-edge science with patient care.
